These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 21797749)
21. Past and present course of cardioprotection against ischemia-reperfusion injury. Liem DA; Honda HM; Zhang J; Woo D; Ping P J Appl Physiol (1985); 2007 Dec; 103(6):2129-36. PubMed ID: 17673563 [TBL] [Abstract][Full Text] [Related]
22. Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infarct Size in Acute Myocardial Infarction. Kapur NK; Qiao X; Paruchuri V; Morine KJ; Syed W; Dow S; Shah N; Pandian N; Karas RH JACC Heart Fail; 2015 Nov; 3(11):873-82. PubMed ID: 26541785 [TBL] [Abstract][Full Text] [Related]
23. GRK2 as a therapeutic target for heart failure. Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798 [TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats. He H; Xu J; Xu Y; Zhang C; Wang H; He Y; Wang T; Yuan D J Ethnopharmacol; 2012 Mar; 140(1):73-82. PubMed ID: 22226974 [TBL] [Abstract][Full Text] [Related]
25. Is oxytocin a therapeutic factor for ischemic heart disease? Alizadeh AM; Mirzabeglo P Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864 [TBL] [Abstract][Full Text] [Related]
26. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Yellon DM; Baxter GF Heart; 2000 Apr; 83(4):381-7. PubMed ID: 10722532 [No Abstract] [Full Text] [Related]
27. The role of secretory phospholipases as therapeutic targets for the treatment of myocardial ischemia reperfusion injury. Ravindran S; Kurian GA Biomed Pharmacother; 2017 Aug; 92():7-16. PubMed ID: 28525795 [TBL] [Abstract][Full Text] [Related]
28. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241 [TBL] [Abstract][Full Text] [Related]
29. A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model. Gatewood LB; Larson DF; Bowers MC; Bond S; Cardy A; Sethi GK; Copeland JG J Heart Lung Transplant; 1996 Sep; 15(9):936-47. PubMed ID: 8889990 [TBL] [Abstract][Full Text] [Related]
30. [Phytoestrogens in application prospect of treatment of myocardial ischemia/reperfusion injury]. Li G; Xing XY; Zhang MS; Shi JJ; Deng XH; Sun GB; Sun XB Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(16):3132-6. PubMed ID: 26790280 [TBL] [Abstract][Full Text] [Related]
32. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications]. Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017 [TBL] [Abstract][Full Text] [Related]
33. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin. Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167 [TBL] [Abstract][Full Text] [Related]
34. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors. Juggi JS; Koenig-Berard E; Van Gilst WH Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428 [TBL] [Abstract][Full Text] [Related]
35. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933 [TBL] [Abstract][Full Text] [Related]
36. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent. Quintana M; Kahan T; Hjemdahl P Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468 [TBL] [Abstract][Full Text] [Related]
38. Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice. Cipolletta E; Gambardella J; Fiordelisi A; Del Giudice C; Di Vaia E; Ciccarelli M; Sala M; Campiglia P; Coscioni E; Trimarco B; Sorriento D; Iaccarino G Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934608 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors. Carotenuto A; Cipolletta E; Gomez-Monterrey I; Sala M; Vernieri E; Limatola A; Bertamino A; Musella S; Sorriento D; Grieco P; Trimarco B; Novellino E; Iaccarino G; Campiglia P Eur J Med Chem; 2013 Nov; 69():384-92. PubMed ID: 24077529 [TBL] [Abstract][Full Text] [Related]
40. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction. Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]